🔎 Trials Near Me

Dachaigh › Galar Alzheimer › Nevada

Sgrùdaidhean clionaigeach Galar Alzheimer ann an Nevada

Tha 8 sgrùdaidhean airson Galar Alzheimer a’ lorg phàirtichean aig làraichean ann an Nevada.

Bailtean ann an Nevada

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Las Vegas
A’ fastadhÌre 2
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06887192

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 2628, Las Vegas
  • Redbird Research, Las Vegas
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06937229

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • Las Vegas Clinical Trials, Las Vegas
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011745

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • Redbird Research, Las Vegas
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011732

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Vector Clinical Trials, Las Vegas
A’ fastadhÌre 3
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • Lou Ruvo Center for Brain Health, Las Vegas
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT07094516

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Cleveland Clinic, Lou Ruvo Center for Brain Health, Las Vegas, Las Vegas
A’ fastadhSgrùdadh amharc
Aoisean 25 gu 55 · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT04165109

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

  • Clinical Neurology Specialists, Las Vegas
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 60 gu 90 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06584357

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.